Rhumbline Advisers Pa Vmed Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.85 - $1.41 $54,922 - $91,107	-64,615 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.16 - $2.5 $806 - $1,737	695 Added 1.09%	64,615 $85,000
Q4 2021 Feb 10, 2022	SELL	$2.46 - $8.74 $4,560 - $16,203	-1,854 Reduced 2.82%	63,920 $157,000
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $14,846 - $27,334	2,911 Added 4.63%	65,774 $562,000
Q2 2021 Aug 05, 2021	BUY	$3.95 - $6.88 $126,593 - $220,497	32,049 Added 104.01%	62,863 $402,000
Q1 2021 May 06, 2021	BUY	$2.01 - $5.55 $10,592 - $29,248	5,270 Added 20.63%	30,814 $137,000
Q4 2020 Feb 10, 2021	BUY	$1.73 - $2.13 $4,844 - $5,964	2,800 Added 12.31%	25,544 $54,000
Q3 2020 Nov 12, 2020	SELL	$1.76 - $2.17 $10,903 - $13,443	-6,195 Reduced 21.41%	22,744 $40,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.65 $50,643 - $76,688	28,939 New	28,939 $61,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.